BECN1
BECN1 encodes Beclin-1, a core autophagy-related protein that plays a central role in the initiation and regulation of autophagosome formation.
BECN1 encodes Beclin-1, a core autophagy-related protein that plays a central role in the initiation and regulation of autophagosome formation. It is widely studied as a key component of the cellular autophagy machinery and is frequently discussed in the context of stress responses, mitochondrial quality control, cell survival, and cell death pathways. In biomedical research, BECN1 is often examined alongside proteins such as BCL2, MAP1LC3B, and Myeloid cell leukemia 1 (MCL1), reflecting its integration into broader networks that balance autophagy and apoptosis.
Functionally, Beclin-1 is important because it helps determine whether cells adapt to stress through autophagy or progress toward injury and death. Recent studies have linked BECN1 to pathways involving AMPK/mTOR, ERN1 (IRE1α), and the Nrf-2-SLC7A11-GSH pathway, as well as to disease contexts including cancer, neurodegeneration, spinal cord injury, osteoporosis, and immune-cell dysfunction. Its activity is also influenced by interactions with BCL2 apoptosis regulator (Bcl-2), which can sequester Beclin-1 and limit autophagy.
Rebuilt from PubMed 18 Sept 2026 · no new papers today
Where the papers sit
9 papers study becn1 directly. Those 9 are one subject: Autophagy in Disease Biology. Autophagy-related mechanisms recur across cancer, neurodegeneration, aging and renal disease. Beclin1-linked pathways connect mitophagy, ferroptosis, lysosomal sequestration and biomarker development, but the work has not converged on a single therapeutic direction. No way of splitting those 9 scores better than chance. 1 new direction follows.
Beclin1 links autophagic degradation to regulation of LSD1-driven DNA-damage senescence and organ aging
In natural aging and irradiation-induced senescence, the LSD1-mediated DNA-damage response study found that Beclin1, together with LC3, participated in autophagosome–lysosome degradation of LSD1 42741942Sep. Whereas the other papers use Beclin1 primarily as an autophagy regulator, tumor suppressor, or component of cancer-treatment pathways, this work assigns it a role in controlling the stability of a DNA-damage-response enzyme and thereby connects autophagic turnover to cellular senescence and organ aging.
Recent Findings on BECN1
Autophagy in Disease Biology: Beclin1-linked autophagy connects organ aging, cancer, neurodegeneration, traumatic brain injury, and diabetic renal lipotoxicity 42741942Sep42645668Aug42183960May42119634May42069296May. Disease context determines whether investigators enhance or restrain the pathway: iTBS and GSTK1 restored autophagy-related activity, whereas XFZYD suppressed pathological autophagy overactivation after traumatic brain injury 42183960May42069296May42119634May. Cancer studies are testing Beclin1-centered interventions that alter autophagy initiation, mitophagy, lysosomal sequestration, or autophagy-dependent ferroptosis 42645668Aug42377685Jun42162690May42060985Apr. Serous ovarian carcinoma showed reduced Beclin-1 expression alongside reduced lncRNA MEG3, but the proposed diagnostic value remains preliminary and requires larger multicenter validation 42446766Jul. The field is moving toward disease-specific pharmacologic, RNA-based, stimulation-based, and biomarker strategies that define when Beclin1 modulation restores cellular homeostasis or creates therapeutic vulnerability 42119634May42060985Apr42446766Jul.
Written from 9 PubMed abstracts, each one cited by PMID above. Published: 2026-06-24. Last written: 2026-09-17 by GPT. Drafted by language models from published abstracts; not medical advice.